Biosensor Technology: Driving Advances in Healthcare

Tech Briefs Media Group

This Webinar will look at biosensors integrated into wearable devices for continuous health monitoring. Biomarkers can be non-invasively monitored in samples such as saliva and exhaled breath condensate as well as minimally invasively in blood and interstitial fluid using smart wristbands.
Watch Now

Spotlight

Flow cytometry is routinely being used as a solution to detect small (~1-3 μm) particles and microparticles (<1.0 μm). Using our newly innovated FSC detection system, the Gallios flow cytometer permits a wide dynamic range of small and micro-particle detection. The Gallios analyzer permits high sensitivity of fluorescence detection; therefore, sub-micron particle detection can be further enhanced using a fluorescence-based discriminator. Together, the Gallios is a superb platform for the identification and characterization of biological small and micro-particles. This technical publication is designed as a resource for investigators performing small and micro-particle research on the Gallios platform.

OTHER ON-DEMAND WEBINARS

Healthcare Investments and Exits

The healthcare industry has seen exponential investment growth over the past several years, with Covid-19 creating enormous disruption and resulting opportunities for new technologies to emerge.
Watch Now

Managing External Health Information

Lorman

As we move into a new era of health care with the increased exchange of medical records in order to provide better, more coordinated care, the question of what information received from outside an organization should be included in a medical record takes on new importance. What with health homes, personal health records, and health information exchanges, as well as increased involvement by patients using digital tools like smart watches and smart phone apps, there is a torrent of information being directed at medical records, and it is essential to understand what belongs there and what should be rejected, and how. This information may come in the form of unsolicited health information, for example, information that is volunteered by patients or by other health care providers, either at the time the patient arrives for treatment or thereafter, and in some cases even after the patient has been discharged.
Watch Now

Supporting Integrated Patient Care by Moving Tests Out of the Core Lab and into Physicians Offices

darkdaily

In an effort to reduce costs, many clinical laboratories and pathology groups have moved to a central lab system where almost all lab tests are sent. This has led to both patients and doctors incurring lengthy wait times often until the next day to learn the results, as well as myriad other inefficiencies.
Watch Now

After COP26 – what will it take to get the NHS to net zero?

The Health Foundation

Our webinar brought together an expert panel to reflect on the outcome of COP26, the challenges and opportunities this presents for decarbonising health care and what this means for the NHS.
Watch Now

Spotlight

Flow cytometry is routinely being used as a solution to detect small (~1-3 μm) particles and microparticles (<1.0 μm). Using our newly innovated FSC detection system, the Gallios flow cytometer permits a wide dynamic range of small and micro-particle detection. The Gallios analyzer permits high sensitivity of fluorescence detection; therefore, sub-micron particle detection can be further enhanced using a fluorescence-based discriminator. Together, the Gallios is a superb platform for the identification and characterization of biological small and micro-particles. This technical publication is designed as a resource for investigators performing small and micro-particle research on the Gallios platform.

resources